Refine Search
(34)
(133)
(339)
(368)

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019’, provides an overview of the Alpha- Antitrypsin Deficiency pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Chemotherapy Induced Anemia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Osteogenesis Imperfecta - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteogenesis Imperfecta - Pipeline Review, H1 2019’, provides an overview of the Osteogenesis Imperfecta pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on...

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Fabry Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H1 2019’, provides an overview of the Fabry Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fabry Disease, com...

Familial Adenomatous Polyposis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Adenomatous Polyposis - Pipeline Review, H1 2019’, provides an overview of the Familial Adenomatous Polyposis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Primary Immune Deficiency (PID) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2019’, provides an overview of the Primary Immune Deficiency (PID) pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subuni...

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2019’, provides in depth analysis on Granulocyte Macrophage Colony Stimulating Factor Receptor S...

P2X Purinoceptor 3 (P2RX3) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019’, provides in depth analysis on P2X Purinoceptor 3 (P2RX3) targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by...

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019’, provides in depth analysis on P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted pipeline therapeutics. The report provides comprehensive informa...

Becker Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Becker Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Crigler-Najjar Syndrome - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2019’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) – Pipeline Review, H1 2019

  • $3,500
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2019’, provides in depth analysis on Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted pipeline therapeutics. The rep...